Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.
about
Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic ResistanceClinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 StrainsImmune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice.Deciphering Adaptation Strategies of the Epidemic Clostridium difficile 027 Strain during Infection through In Vivo Transcriptional Analysis.CdtR Regulates TcdA and TcdB Production in Clostridium difficileClostridium difficile colitis: pathogenesis and host defenceDetermining Clostridium difficile intra-taxa diversity by mining multilocus sequence typing databases.Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model.Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.Clostridial Binary Toxins: Basic Understandings that Include Cell Surface Binding and an Internal "Coup de Grâce".Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative.Complete genome sequence of Peptoclostridium difficile strain Z31.Effective Sequestration of Clostridium difficile Protein Toxins by Calcium AluminosilicatePreterm Infant-Associated Clostridium tertium, Clostridium cadaveris, and Clostridium paraputrificum Strains: Genomic and Evolutionary Insights.Cyclic-di-GMP regulation of virulence in bacterial pathogens.The role of toxins in Clostridium difficile infection.Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection.Novel Cysteine Desulfidase CdsB Involved in Releasing Cysteine Repression of Toxin Synthesis in Clostridium difficile.Using bugs as drugs: Microbial ecosystem therapeutics.Effect of the Synthetic Bile Salt Analog CamSA on the Hamster Model of Clostridium difficile Infection
P2860
Q26771995-B3E2C42F-88BC-42F5-96A3-6796675B8114Q28354123-4211B318-6BA4-45EE-9B41-8CF17A48D053Q33575993-A44B8F98-F438-432C-91CD-2F39DC2A869EQ36063209-F904B18F-1458-4D25-9FB6-2E3B72A3A39EQ36077222-24CB4915-B9E5-42AA-9395-963BFD63C098Q36116428-D503EDED-B900-4BAA-9207-E0682124CEE3Q36306533-9178BF54-86FC-4F5A-A344-FF7A1B9C9E4EQ38633032-D5F8C292-E709-4B1A-BAFB-568CAB46764DQ38765888-10533EB3-FCC4-4487-9DF0-5B8F49E05313Q38845075-CA038315-4713-41A4-A5BA-9E56B7D26DEEQ40169068-9163E84C-A10D-4685-835B-D08366F3D7E0Q40735474-52C46CD4-9BAC-4D26-BD28-7636DF640D6AQ41120077-39CA1795-EE43-4F1E-8CEB-74A395A689A4Q42675415-C12961D9-7482-4870-8BC6-1C16A7D7A755Q47679214-0CD28CC0-5414-40EF-967C-DD745FAADA67Q47734724-845979DF-7DF0-45ED-AD8A-996517BFC7BAQ49201152-574474D6-2C9E-4081-867E-DAC81800D6B5Q49203248-B4E1D6DD-00DC-499F-A492-7562601BDB0CQ54207972-84D21208-3A8F-46A3-A872-51125D26CA0DQ57107809-34EE2C37-A0DC-47E8-BD8B-9ED9DFD91203
P2860
Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Clostridium difficile virulenc ...... erobic spore-forming pathogen.
@ast
Clostridium difficile virulenc ...... erobic spore-forming pathogen.
@en
type
label
Clostridium difficile virulenc ...... erobic spore-forming pathogen.
@ast
Clostridium difficile virulenc ...... erobic spore-forming pathogen.
@en
prefLabel
Clostridium difficile virulenc ...... erobic spore-forming pathogen.
@ast
Clostridium difficile virulenc ...... erobic spore-forming pathogen.
@en
P2093
P2860
P1433
P1476
Clostridium difficile virulenc ...... erobic spore-forming pathogen.
@en
P2093
Dena Lyras
Edward Rose
Glen P Carter
Milena M Awad
Priscilla A Johanesen
P2860
P304
P356
10.4161/19490976.2014.969632
P577
2014-01-01T00:00:00Z